ARCHIVES

In Brief: Abeloff, Fisher Lead ASCO; Henney Replaces Antman On Govt. Relations; Ultmann Retires

This article is from The Cancer Letter archive.

Vol. 17 No. 22 | May 31, 1991

Download PDF Visit The Full Archive

Related Articles

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

SWOG Phase III Trial To Test Treatment For Inoperable, Locally Advanced NSCLC

September 28, 2001

Cancer Mortality Increase Of 5.2% Now 28% Or Less

January 30, 1976

Court Could Determine Future of Clinical Trials in Abigail Alliance Case.

February 9, 2007

Elizabeth Miller Will Be Named to Cancer Panel

June 17, 1977

NCI CTEP-Approved Trials For the Month of September

September 26, 2014